Backs FY25 revenue view $1.37B, consensus $1.37B. The company said, “CONMED (CNMD) does not expect a material impact on its 2025 financial results and is reaffirming its prior guidance range for revenue and adjusted EPS.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNMD: